Urokinase, a key enzyme in the fibrinolytic system, is essential for breaking down blood clots. Its activity is tightly regulated, and understanding its inhibition is vital for treating conditions like thrombosis and promoting wound healing.

4-Aminobenzamidine Dihydrochloride emerges as a significant chemical entity in this research domain due to its efficacy as a urokinase inhibitor.

As a leading manufacturer in China, NINGBO INNO PHARMCHEM CO.,LTD. supplies high-quality 4-Aminobenzamidine Dihydrochloride, a critical pharmaceutical intermediate. This compound's ability to selectively inhibit urokinase makes it an indispensable tool for scientists exploring the complexities of blood coagulation and clot dissolution. Researchers often look for this specific chemical to buy for their in-depth studies.

The availability of 4-Aminobenzamidine Dihydrochloride at a reasonable price point further encourages its widespread use in academic and industrial research laboratories. Its application spans from in vitro studies of enzyme kinetics to its potential role in the development of novel anticoagulant or thrombolytic agents. NINGBO INNO PHARMCHEM CO.,LTD. ensures that its products meet stringent quality standards, providing researchers with the confidence they need in their experimental materials.

By utilizing this effective urokinase inhibitor, researchers can gain deeper insights into the fibrinolytic pathway, paving the way for advancements in cardiovascular disease treatment and other related medical fields. The commitment of NINGBO INNO PHARMCHEM CO.,LTD. to providing essential research chemicals like 4-Aminobenzamidine Dihydrochloride underscores its dedication to fostering scientific progress globally.